Beta-blockers and non-cardiac operations what will change after the POISE study?: ?qué cambia después del estudio POISE?
Gualandro
Danielle Menosi
DM
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. danigualandro@cardiol.br
Calderaro
Daniela
D
Yu
Pai Ching
PC
Marques
Andre Coelho
AC
Caramelli
Bruno
B
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000009:adverse effects; D009203:Myocardial Infarction / Q000517:prevention & control; D019990:Perioperative Care / Q000379:methods / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000139:chemically induced; D013514:Surgical Procedures, Operative / Q000379:methods*
D000319:Adrenergic beta-Antagonists; D008790:Metoprolol